Vitamin D2 and D3 Separation by New Highly Hydrophobic UHPLC/HPLC Phase
The Application Notebook
Separations of structurally similar compounds such as vitamin D2 and vitamin D3 are very challenging.
Vitamin D2 (ergocalciferol) and D3 (cholecalciferol) can be found in different foods including fatty fishes, meat, egg, and some mushrooms. Both compounds are (indirectly) involved in a number of biological functions in the body, including bone metabolism and enhancement of intestinal absorption of calcium, iron, magnesium, phosphate, and zinc. A regular intake of vitamin D therefore is essential.
Figure 1: Structures of vitamin D2 and vitamin D3.
Standard C18 columns are not able to fully separate the two vitamins. A very hydrophobic phase with a higher carbon coverage and therefore a greater density of C18 chains is required. The highly hydrophobic phase YMC-Triart C18 ExRS (carbon load 25%!) is able to separate these two.
Figure 2: Easy method transfer HPLC <-> UHPLC as a result of full scalability.
The isocratic high performance liquid chromatography (HPLC) method for vitamin D2 and D3 separation, using a 5 μm YMC-Triart C18 ExRS column, can easily be transferred to a ultrahigh-performance liquid chromatography (UHPLC) method using a 1.9 μm column, thereby reducing the analysis time by 50%. Furthermore, the resolution can be increased, resulting in a full baseline separation.
YMC-Triart C18 ExRS (5 µm, 8 nm), 150 × 3.0 mm
YMC-Triart C18 ExRS (1.9 µm, 8 nm),
75 × 2.1 mm
YMC Europe GmbH
Phone: +49 2064 4270
E-mail: info@ymc.de
Website: www.ymc.de
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
